ALERCE INVESTMENT MANAGEMENT, L.P.
ALERCE INVESTMENT MANAGEMENT, L.P. is a Series A, Series B and Series C+ fund in the US and global investing in Healthcare, healthcare-tech, medical-devices and healthcare-services.
- Stages
- Series A, Series B, Series C+
- Sectors
- Healthcare, healthcare-tech, medical-devices, healthcare-services
- Invests in
- US-wide, global
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2016
- Assets under management
- $223 million
Check size not disclosed
Thesis
Alerce Investment Management, L.P. is a private equity firm founded in 2016 and headquartered in Chicago, Illinois. The firm primarily focuses on the medical technology sector, encompassing biotechnology drugs and therapies, medical devices, and healthcare services. Their investment strategy targets companies developing life-saving or life-altering products, possessing strong intellectual property and sustainable barriers to entry, and demonstrating robust clinical data. While generally avoiding pre-clinical research companies, Alerce may consider exceptions. A key aspect of their strategy is to invest in companies offering cost-effective solutions to the medical system, thereby increasing the likelihood of reimbursement approvals. Alerce Investment Management acts as a lead investor in its transactions. As of December 31, 2024, the firm managed approximately $223 million in client assets. They invest in both privately held and publicly traded operating entities.
Common questions
Does ALERCE INVESTMENT MANAGEMENT, L.P. invest at the Series A stage?
Yes. ALERCE INVESTMENT MANAGEMENT, L.P. lists Series A, Series B and Series C+ among the stages it invests in.
Where does ALERCE INVESTMENT MANAGEMENT, L.P. invest?
ALERCE INVESTMENT MANAGEMENT, L.P. invests in the US and global.